Cargando…
Border Zones of Evidence: How Non-evidence Based Factors Influence Evidence Generation and Clinical Practice in Stroke Medicine
The interpretation of the results of clinical trials should be done by examining the finer prints of extraneous factors such as stopping rules, interim analysis, intricacies of patient selection, and the rationale of decisions that lead to non-prespecified termination. This can be done only by criti...
Autores principales: | Srijithesh, PR, Husain, Shakir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313603/ https://www.ncbi.nlm.nih.gov/pubmed/32606506 http://dx.doi.org/10.4103/aian.AIAN_15_20 |
Ejemplares similares
-
Homogeneity and the outcome of clinical trials: An appraisal of the outcome of recent clinical trials on endovascular intervention in acute ischemic stroke
por: Husain, Shakir, et al.
Publicado: (2016) -
Influence of trial design, heterogeneity and regulatory environment on the results of clinical trials: An appraisal in the context of recent trials on acute stroke intervention
por: Srijithesh, P. R., et al.
Publicado: (2014) -
No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
por: Pandit, Lekha
Publicado: (2019) -
Non-Health Subjects in Community Medicine: How Much Healthy or Medicinal are They?
por: Mohapatra, Sadhu Charan
Publicado: (2017) -
SARS-CoV2 coronavirus: so far polite with children. Debatable immunological and non-immunological evidence
por: Álvez, F.
Publicado: (2020)